News

Elieen, Actual Sientra Patient

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Sientra Reports Record Second Quarter Financial and Operational Results August 10, 2023
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023 July 27, 2023
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 30, 2023
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors June 20, 2023
Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander June 8, 2023
Sientra Announces FDA-Clearance of Novel Portfinder™ Technology May 17, 2023
Sientra Reports Record First Quarter 2023 Operational Results May 11, 2023
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023 May 1, 2023
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches March 30, 2023
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction March 22, 2023
Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 March 20, 2023
Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality™ Fat Transfer System March 1, 2023
Sientra Announces 1-for-10 Reverse Stock Split January 20, 2023

Nasdaq: SIEN

Stock Quote: NASD

$2.78 +0.18
Volume 79,336
Previous Close 2.60
Intraday High 2.84
Intraday Low 2.60
Pricing delayed 20 minutes
Price Change % Change +6.92% 52 Week High 8.88 52 Week Low 1.25 Today's Open 2.65 Sep 29, 2023 04:00 PM

Email Alerts

Email: *
Subscription Preferences *




 
Enter the code shown above.

Investor Contact

Sientra Investor Relations
ir@sientra.com

© 2021 Sientra, Inc. All rights reserved.